Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Cash-strapped biotechs find financing alternative

Nature Biotechnology volume 22, pages 1057–1058 (2004)Cite this article

An Erratum to this article was published on 01 December 2004

Publicly quoted biotech companies increasingly rely on private investors to raise money

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. London

    Peter Mitchell

Authors
  1. Peter Mitchell
    View author publications

    You can also search for this author in PubMed Google Scholar

Related links

Related links

Related links in Nature Research

IPO floodgates unlikely to open after Ark floatation

IPO plans sour on both sides of the pond

Related external links

Private Raise

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mitchell, P. Cash-strapped biotechs find financing alternative. Nat Biotechnol 22, 1057–1058 (2004). https://doi.org/10.1038/nbt0904-1057

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0904-1057

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing